July 20, 2023
Melbourne, Australia – Nicolab, a publicly unlisted Australian-based company, and Titan Neuroscience Research Australia, a Melbourne-based health technology R&D firm, are pleased to announce the formal signing of a Memorandum of Understanding (MOU) between the two organisations. The MOU outlines the establishment of a collaborative partnership aimed at leveraging their respective resources and expertise.
This MOU signifies the unwavering commitment of both organisations to revolutionise pre-hospital workflow through the implementation of an AI-driven clinical decision support and workflow solution. The primary focus of this partnership will initially be directed towards enhancing acute stroke services.
Nicolab specialises in cutting-edge technology for digital telehealth services, particularly in stroke diagnosis and triage, exemplified by their world-renowned StrokeViewer product.
Titan is a leading healthcare research company that specialises in delivering digital health technologies and AI-powered clinical decision assistance technologies. Its digital telestroke platform, Zeus, integrates essential features such as online clinical forms, patient geo-tracking, direct ambulance-to- neurologist communication, and enables rapid triage for stroke patients.
Bringing together Nicolab’s StrokeViewer solution and Titan’s Zeus solution sets the foundation for a revolutionary approach to diagnosing, assessing, and treating stroke and other acute diseases. By combining their efforts, the two companies aim to equip healthcare professionals with an innovative tool that empowers them to make faster, more accurate decisions, ultimately saving lives and reducing long-term disabilities.
Regional and remote Australians are 17% more likely to experience a stroke, and patients who are diagnosed and treated as quickly as possible have a greater chance of recovery. It is anticipated that the technology and expertise developed from this partnership will particularly benefit regional, remote and Indigenous Australians.
“We are thrilled to embark on this transformative journey. Together, we share a vision of how our disruptive technology will shape the future of healthcare and revolutionise pre-hospital workflow,” stated Michael Macilquham, Chief Commercial Officer at Nicolab.
Prof Mark Parsons, a world-leading stroke neurologist and Co-Founder of Titan, expressed his enthusiasm for the collaboration: “this development highlights the immense potential of Australian industry and medical research partnerships to drive technology innovation in the prehospital space. Early in 2023 we were pleased to see that Zeus had delivered a positive impact for acute stroke care in South Australia. We are excited to be exploring how StrokeViewer and Zeus can further transform acute care for stroke patients and optimise health service delivery more broadly.”
StrokeViewer incorporates deep learning algorithms that analyse computed tomography (CT) scans to identify and quantify critical stroke-related parameters. By automating the detection and segmentation of ischaemic regions, StrokeViewer empowers physicians to make faster and more accurate treatment decisions, ultimately leading to improved patient outcomes.
Nicolab’s vision is to empower healthcare professionals with quick and reliable access to information when it matters most. By providing physicians with all necessary information at their fingertips, they can diagnose patients more accurately and make faster treatment decisions. Nicolab’s algorithms analyse and aggregate complex medical imaging data into an easy to use workflow to streamline acute clinical care.
About Titan Neuroscience Australia
Titan Neuroscience Australia’s mission is to transform prehospital care. Bringing together leaders in clinical research and implementation, Titan equips paramedics with new digital tools and advanced training to enhance their clinical workflows. Titan’s unique multidisciplinary expertise, data analytics platforms and clinical trials network helps health partners expedite clinical implementation of new technologies and models of care.
For further information please contact:
Titan Neuroscience Research Australia
0439 636 279
Country Manager, ANZ
0482 036 457